1. Introduction
===============

Among the diterpenoids isolated from octocorals, the 3,8-cyclized cembranoidal diterpenes (briarane) are major representative compounds. Briarane-type natural products are found only in marine organisms and mainly from octocorals \[[@B1-marinedrugs-13-01037],[@B2-marinedrugs-13-01037],[@B3-marinedrugs-13-01037],[@B4-marinedrugs-13-01037],[@B5-marinedrugs-13-01037]\]. The compounds of this type are suggested to be originally synthesized by host corals \[[@B6-marinedrugs-13-01037],[@B7-marinedrugs-13-01037]\] and have been proven to possess various interesting bioactivities \[[@B1-marinedrugs-13-01037],[@B2-marinedrugs-13-01037],[@B3-marinedrugs-13-01037],[@B4-marinedrugs-13-01037],[@B5-marinedrugs-13-01037]\]. The octocorals belonging to the genus *Briareum* (phylum Cnidaria, class Anthozoa, subclass Octocorallia, order Gorgonacea, suborder Scleraxonia, family Briareidae) have been proven to be the most important source of briarane analogues \[[@B1-marinedrugs-13-01037],[@B2-marinedrugs-13-01037],[@B3-marinedrugs-13-01037],[@B4-marinedrugs-13-01037],[@B5-marinedrugs-13-01037]\]. The genus *Briareum* is distributed widely in the Indo-Pacific Ocean and the Caribbean Sea and is placed taxonomically within the orders Gorgonacea and Alcyonacea \[[@B8-marinedrugs-13-01037],[@B9-marinedrugs-13-01037],[@B10-marinedrugs-13-01037],[@B11-marinedrugs-13-01037]\]. Previous chemical investigations of octocorals belonging to the genus *Briareum*, collected off the waters of Taiwan, at the intersection of the Kuroshio current and the South China Sea surface current, have yielded numbers of briarane analogues \[[@B12-marinedrugs-13-01037],[@B13-marinedrugs-13-01037],[@B14-marinedrugs-13-01037],[@B15-marinedrugs-13-01037],[@B16-marinedrugs-13-01037],[@B17-marinedrugs-13-01037],[@B18-marinedrugs-13-01037],[@B19-marinedrugs-13-01037],[@B20-marinedrugs-13-01037],[@B21-marinedrugs-13-01037],[@B22-marinedrugs-13-01037],[@B23-marinedrugs-13-01037],[@B24-marinedrugs-13-01037],[@B25-marinedrugs-13-01037],[@B26-marinedrugs-13-01037],[@B27-marinedrugs-13-01037],[@B28-marinedrugs-13-01037],[@B29-marinedrugs-13-01037],[@B30-marinedrugs-13-01037],[@B31-marinedrugs-13-01037],[@B32-marinedrugs-13-01037],[@B33-marinedrugs-13-01037],[@B34-marinedrugs-13-01037],[@B35-marinedrugs-13-01037],[@B36-marinedrugs-13-01037],[@B37-marinedrugs-13-01037],[@B38-marinedrugs-13-01037],[@B39-marinedrugs-13-01037],[@B40-marinedrugs-13-01037],[@B41-marinedrugs-13-01037],[@B42-marinedrugs-13-01037],[@B43-marinedrugs-13-01037],[@B44-marinedrugs-13-01037]\]. In our continuing studies of this interesting organism, a sample collected at the Southern Tip, Taiwan, identified as *Briareum* sp. \[[@B45-marinedrugs-13-01037],[@B46-marinedrugs-13-01037],[@B47-marinedrugs-13-01037],[@B48-marinedrugs-13-01037],[@B49-marinedrugs-13-01037]\], yielded two new briaranes, briarenolides K (**1**) ([Scheme 1](#marinedrugs-13-01037-f004){ref-type="scheme"} and [Supplementary Figures S1--S7](#marinedrugs-13-01037-s001){ref-type="supplementary-material"}) and L (**2**) ([Scheme 1](#marinedrugs-13-01037-f004){ref-type="scheme"} and [Supplementary Figures S8--S14](#marinedrugs-13-01037-s001){ref-type="supplementary-material"}). In this paper, we report the isolation, structure determination and anti-inflammatory activity of briaranes **1** and **2**.

![The octocoral *Briareum* sp. and the structures of briarenolides K (**1**) and L (**2**).](marinedrugs-13-01037-g004){#marinedrugs-13-01037-f004}

2. Results and Discussion
=========================

Briarenolide K (**1**), $\left\lbrack \alpha \right\rbrack_{D}^{27}$ −291 (*c* 0.2, CHCl~3~), was isolated as a white powder. The molecular formula of **1** was established as C~26~H~34~O~12~ (ten degrees of unsaturation) from a sodium adduct at *m/z* 561 in the electrospray ionization mass spectrum (ESIMS) and further supported by the high-resolution electrospray ionization mass spectrum (HRESIMS) at *m/z* 561.19435 (calcd. for C~26~H~34~O~12~ + Na, 561.19425). The IR spectrum of **1** showed bands at 3366, 1781 and 1733 cm^−1^, consistent with the presence of hydroxy, γ-lactone and ester carbonyl groups.
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^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data and ^1^H--^1^H COSY and HMBC correlations for briarane **1**.

  Position   δ~H~ (*J* in Hz)                 δ~C~, Multiple   ^1^H--^1^H COSY       HMBC
  ---------- -------------------------------- ---------------- --------------------- --------------------------------
  1                                           39.2, C                                
  2          3.12 br d (9.6)                  75.9, CH         H-3, OH-2             n\. o. ^a^
  3          3.31 dd (9.6, 4.0)               60.3, CH         H-2, H-4              C-1
  4          4.09 br s                        58.2, CH         H-3, H-6              n .o.
  5                                           136.3, C                               
  6          5.81 dddd (9.2, 1.2, 0.8, 0.8)   122.9, CH        H-4, H-7, H~2~-16     C-16
  7          5.32 d (9.2)                     76.6, CH         H-6                   C-5, -8
  8                                           81.8, C                                
  9          5.35 d (8.4)                     69.3, CH         H-10                  C-8, -17, acetate carbonyl
  10         1.82 dd (8.4, 2.4)               36.8, CH         H-9, H-11             C-1, -2, -8, -9, -11, -15, -20
  11         2.17 m                           36.5, CH         H-10, H-12, H~3~-20   n\. o.
  12         4.94 d (4.8)                     71.7, CH         H-11, H-13            C-10, -11, -13, -14, -20,
                                                                                     acetate carbonyl
  13         3.27 d (4.0)                     58.1, CH         H-12, H-14            C-1
  14         3.34 d (4.0)                     62.7, CH         H-13                  C-1, -10
  15         1.20 s                           15.2, CH~3~                            C-1, -2, -10, -14
  16a        4.67 d (15.6)                    64.6, CH~2~      H-6, H-16b            C-5, -6
  b          4.80 d (15.6)                                     H-6, H-16a            C-5, -6
  17         2.39 q (6.8)                     43.7, CH         H~3~-18               C-18, -19
  18         1.21 d (6.8)                     6.3, CH~3~       H-17                  C-8, -17, -19
  19                                          175.6, C                               
  20         1.08 d (6.8)                     9.7, CH~3~       H-11                  C-10, -11, -12
  9-OAc                                       169.5, C                               
             2.20 s                           21.8, CH~3~                            Acetate carbonyl
  12-OAc                                      170.3, C                               
             2.11 s                           21.0, CH~3~                            Acetate carbonyl
  16-OAc                                      172.2, C                               
             2.19 s                           21.2, CH~3~                            Acetate carbonyl
  OH-2       3.55 br s                                         H-2                   n\. o.
  OH-8       3.73 br s                                                               n\. o.

^a^ n. o. = not observed.

The ^13^C NMR and distortionless enhancement polarization transfer (DEPT) spectral data showed that this compound has 26 carbons ([Table 1](#marinedrugs-13-01037-t001){ref-type="table"}), including six methyls, an sp^3^ oxymethylene, eleven sp^3^ methines (including eight oxymethines), two sp^3^ quaternary carbons (including an oxygenated quaternary carbon), an sp^2^ methine and five sp^2^ quaternary carbons (including four carbonyls). From ^1^H and ^13^C NMR spectra ([Table 1](#marinedrugs-13-01037-t001){ref-type="table"}), **1** was found to possess three acetoxy groups (δ~H~ 2.20, 2.19, 2.11, each 3H × s; δ~C~ 169.5, 172.2, 170.3, 3 × C; 21.8, 21.2, 21.0, 3 × CH~3~), a γ-lactone moiety (δ~C~ 175.6, C-19) and a trisubstituted olefin (δ~H~ 5.81, 1H, dddd, *J* = 9.2, 1.2, 0.8, 0.8 Hz, H-6; δ~C~ 136.3, C-5; 122.9, CH-6). The presence of two disubstituted epoxy groups was established from the signals of four oxymethines at δ~C~ 60.3 (CH-3), 58.2 (CH-4), 58.1 (CH-13) and 62.7 (CH-14) and further confirmed by the proton signals at δ~H~ 3.31 (1H, dd, *J* = 9.6, 4.0 Hz, H-3), 4.09 (1H, br s, H-4), 3.27 (1H, d, *J* = 4.0 Hz, H-13) and 3.34 (1H, d, *J* = 4.0 Hz, H-14). On the basis of the above unsaturation data, **1** was concluded to be a diterpenoid molecule possessing five rings.

From the ^1^H--^1^H correlation spectroscopy (COSY) spectrum of **1** ([Table 1](#marinedrugs-13-01037-t001){ref-type="table"}), it was possible to establish the separate system that maps out the proton sequences from H-2/H-3/H-4, H-4/H-6 (by allylic coupling), H-6/H-7 and H-9/H-10. These data, together with the heteronuclear multiple-bond coherence (HMBC) correlations between H-3/C-1, H-7/C-5, -8, H-9/C-8 and H-10/C-1, -2, -8, -9, established the connectivity from C-1 to C-10 in the ten-membered ring ([Table 1](#marinedrugs-13-01037-t001){ref-type="table"}). The methylcyclohexane ring, which is fused to the ten-membered ring at C-1 and C-10, was elucidated by the ^1^H--^1^H COSY correlations between H-10/H-11/H-12/H-13/H-14 and H-11/H~3~-20 and by the HMBC correlations between H-10/C-11, -20, H-12/C-10, -11, -13, -14, -20, H-13/C-1, H-14/C-1, -10 and H~3~-20/C-10, -11, -12. The ring junction C-15 methyl group was positioned at C-1 from the HMBC correlations between H~3~-15/C-1, -2, -10, -14 and H-10/C-15. The acetate esters at C-9 and C-12 were established by the correlations between H-9 (δ~H~ 5.35), H-12 (δ~H~ 4.94) and the acetate carbonyls at δ~C~ 169.5 and 170.3, respectively, in the HMBC spectrum of **1**. The methyl acetate group at C-5 was confirmed by the HMBC correlations between the oxygen-bearing methylene protons at δ~H~ 4.67 and 4.80 (H-16a/b) and the olefinic carbons C-5 and C-6; and further confirmed by the allylic couplings between H~2~-16 and H-6, although there is no HMBC correlation found between H~2~-16 and the acetate carbonyl at δ~C~ 172.2. The presence of a hydroxy group at C-2 was deduced from the ^1^H--^1^H COSY correlation between a hydroxy proton (δ~H~ 3.55) and H-2 (δ~H~ 3.12). Thus, the remaining hydroxy group is positioned at C-8 and an oxygen-bearing quaternary carbon at δ~C~ 81.8. These data, together with the ^1^H--^1^H COSY correlation between H-17 and H~3~-18 and the HMBC correlations between H-9/C-17, H-17/C-18, -19 and H~3~-18/C-8, -17, -19, were used to establish the molecular framework of **1**.

In all naturally-occurring briarane-type natural products, H-10 is *trans* to the C-15 methyl group at C-1, and these two groups are assigned as α- and β-oriented in most briarane derivatives \[[@B1-marinedrugs-13-01037],[@B2-marinedrugs-13-01037],[@B3-marinedrugs-13-01037],[@B4-marinedrugs-13-01037],[@B5-marinedrugs-13-01037]\]. The relative configuration of **1** was elucidated from the interactions observed in a nuclear Overhauser effect spectroscopy (NOESY) experiment and was found to be compatible with that of **1** offered by computer modeling ([Figure 1](#marinedrugs-13-01037-f001){ref-type="fig"}) \[[@B50-marinedrugs-13-01037]\] and that obtained from vicinal proton coupling constant analysis. In the NOESY experiment of **1**, the correlations of H-10 with H-2, H-11 and H-12, but not with H~3~-15 and H~3~-20, indicated that H-2, H-10, H-11 and H-12 were situated on the same face and were assigned as α protons, since the Me-15 and Me-20 are β-substituents at C-1 and C-11, respectively. H-14 showed correlations with H-13 and Me-15, but not with H-10, as well as a lack of coupling was detected between H-12 and H-13, indicating that the dihedral angle between H-12 and H-13 is approximately 90° and the 13,14-epoxy group has an α-orientation \[[@B51-marinedrugs-13-01037]\]. H-9 was found to show responses to H-11, H~3~-18 and H~3~-20. From modeling analysis, H-9 was found to be close H-11, H~3~-18 and H~3~-20 when H-9 was α-oriented. H-3 correlated with Me-15 and H-4, but not with H-2 and H-10, and a large coupling constant (*J* = 9.6 Hz) was detected between H-2 and H-3, indicating that the 3,4-epoxy group was α-oriented. In addition, H-4 showed a correlation with H-7, and a large coupling constant (*J* = 9.2 Hz) was detected between H-6 and H-7, indicating that the dihedral angle between H-6 and H-7 is approximately 180°, and H-7 was β-oriented \[[@B51-marinedrugs-13-01037]\]. Furthermore, H-7 exhibited a correlation with H-17, but not with the C-8 hydroxy proton, suggesting that the H-17 and 8-hydroxy group were β- and α-oriented in the γ-lactone moiety, respectively, by modeling analysis. Based on the above findings, the structure of **1** was established unambiguously.

![The computer-generated model of **1** using MM2 force field calculations and the calculated distances (Å) between selected protons with key NOESY correlations.](marinedrugs-13-01037-g001){#marinedrugs-13-01037-f001}

Briarenolide L (**2**) had a molecular formula of C~30~H~42~O~11~ as deduced from HRESIMS at *m/z* 601.26221 (C~30~H~42~O~11~ + Na, calcd. 601.26193). Thus, ten degrees of unsaturation were determined for **2**. The IR spectrum showed bands at 3461, 1780 and 1739 cm^−1^, consistent with the presence of hydroxy, γ-lactone and ester carbonyl groups in the structure of **2**. From the ^13^C spectral data of **2** ([Table 2](#marinedrugs-13-01037-t002){ref-type="table"}), two trisubstituted olefins were deduced from the signals of four carbons at δ~C~ 143.2 (C-5), 121.2 (CH-6), 131.6 (C-11) and 122.2 (CH-12). In the ^13^C NMR spectrum of **2**, five carbonyl resonances at δ~C~ 176.1, 172.3, 170.3, 169.8 and 169.2 (5 × C) confirmed the presence of a γ-lactone and four other ester groups. In the ^1^H NMR spectrum of **2** ([Table 2](#marinedrugs-13-01037-t002){ref-type="table"}), an *n*-butyrate group (δ~H~ 0.94, 3H, t, *J* = 7.2 Hz; 1.60, 2H, m; 2.21, 2H, t, *J* = 7.6 Hz) and three acetyl methyls (δ~H~ 2.24, 2.10, 1.98, each 3H × s) were observed. Based on the above data, metabolite **2** was found to be a tricyclic compound.

^1^H--^1^H couplings in the COSY spectrum of **2** enabled identification of the C-2/-3/-4, C-6/-7, C-9/-10, C-12/-13/-14, C-6/-16 (by allylic coupling), C-12/C-20 (by allylic coupling) and C-17/-18 units ([Table 2](#marinedrugs-13-01037-t002){ref-type="table"}), which were assembled with the assistance of an HMBC experiment. The HMBC correlations between the protons and carbons of **2**, such as H-4α/C-5, H-4β/C-3, H-6/C-4, -5, -8, H-7/C-6, H-9/C-1, -7, -8, -10, -11, -17, H-10/C-8, -9, -11, -12, -14, H-13α/C-12, H-14/C-2, H-17/C-8, -18, -19 and H~3~-18/C-8, -17, -19, permitted the elucidation of the main carbon skeleton of **2** ([Table 2](#marinedrugs-13-01037-t002){ref-type="table"}). The vinyl methyls at C-5 and C-11 were confirmed by the HMBC correlations between H~3~-16/C-4, -5, -6 and H~3~-20/C-10, -11, -12 and further supported by the allylic couplings between H-6/H~3~-16 and H-12/H~3~-20, respectively. The C-15 methyl group was positioned at C-1 from the HMBC correlations between H~3~-15/C-1, -2, -10, -14. In addition, the carbon signal at δ~C~ 172.3 (C) was correlated with the signal of the methylene protons at δ~H~ 2.21 and 1.60 in the HMBC spectrum and was consequently assigned as the carbon atom of the *n*-butyrate carbonyl. The acetate esters at C-2 and C-9 were established by the correlations between H-2 (δ~H~ 5.51), H-9 (δ~H~ 5.34) and the acetate carbonyls at δ~C~ 169.2 and 169.8, respectively, observed in the HMBC spectrum of **2**. Due to the absence of HMBC correlations for H-3 (δ~H~ 4.76) and H-14 (δ~H~ 4.92) and the ester carbonyls, the positions for the remaining acetoxy and *n*-butyroxy groups could not be determined by this method.
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^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data and ^1^H--^1^H COSY and HMBC correlations for briarane **2**.

  Position                 δ~H~ (*J* in Hz)           δ~C~, Multiple   ^1^H--^1^H COSY     HMBC
  ------------------------ -------------------------- ---------------- ------------------- -----------------------------
  1                                                   42.1, C                              
  2                        5.51 d (3.6)               72.5, CH         H-3                 Acetate carbonyl
  3                        4.76 ddd (3.6, 3.2, 3.2)   72.3, CH         H-2, H~2~-4         n\. o.
  4α                       2.13 m                     33.7, CH~2~      H-3, H-4β           C-5
  β                        3.31 dd (16.0, 3.2)                         H-3, H-4α           C-3
  5                                                   143.2, C                             
  6                        5.53 s                     121.2, CH        H-7, H~3~-16        C-4, -5, -8, -16
  7                        5.53 s                     79.8, CH         H-6                 C-6
  8                                                   84.6, C                              
  9                        5.34 d (1.2)               77.2, CH         H-10                C-1, -7, -8, -10, -11, -17,
                                                                                           acetate carbonyl
  10                       2.96 br s                  43.8, CH         H-9                 C-8, -9, -11, -12, -14
  11                                                  131.6, C                             
  12                       5.49 br s                  122.2, CH        H~2~-13, H~3~-20    n\. o.
  13α                      2.17 m                     28.2, CH~2~      H-12, H-13β, H-14   C-12
  β                        2.35 m                                      H-12, H-13α, H-14   n\. o.
  14                       4.92 dd (10.0, 7.2)        73.5, CH         H~2~-13             C-2
  15                       1.59 s                     17.3, CH~3~                          C-1, -2, -10, -14
  16                       1.85 br s                  23.9, CH~3~      H-6                 C-4, -5, -6
  17                       2.91 q (7.2)               42.1, CH         H~3~-18             C-8, -18, -19
  18                       1.11 d (7.2)               7.4, CH~3~       H-17                C-8, -17, -19
  19                                                  176.1, C                             
  20                       1.79 d (1.2)               22.2, CH~3~      H-12                C-10, -11, -12
  2-OAc                                               169.2, C                             
                           2.10 s                     21.0, CH~3~                          Acetate carbonyl
  9-OAc                                               169.8, C                             
                           2.24 s                     21.0, CH~3~                          Acetate carbonyl
  14-OAc                                              170.3, C                             
                           1.98 s                     21.0, CH~3~                          Acetate carbonyl
  3-OC(O)CH~2~CH~2~CH~3~                              172.3, C                             
  1′ 2′ 3′ 4′              2.21 t (7.6)               35.9, CH~2~      H~2~-3′             C-1′, -3′, -4′
                           1.60 m                     18.0, CH~2~      H~2~-2′, H~3~-4′    C-1′, -2′, -4′
                           0.94 t (7.2)               13.6, CH~3~      H~2~-3′             C-2′, -3′

^a^ n. o. = not observed.

NOESY measurements were carried out in order to deduce the relative stereochemical features of **2** ([Figure 2](#marinedrugs-13-01037-f002){ref-type="fig"}). Thus, H~3~-15 gave a correlation with H-14, but not with H-10, indicating that Me-15 and H-14 are located on the same face (assigned as the β-face) and that H-10 lies on the opposite side, the α-face. It was found that one of the methylene protons at C-4 (δ~H~ 3.31) exhibited correlations with H~3~-15 and H-7, but not with H-3, and therefore, it was assigned as H-4β and the other C-4 proton (δ~H~ 2.13) as H-4α. H-10 showed correlations with H-2, H-3 and H-9, indicating that the ester groups at C-2, C-3 and C-9 were β-oriented. Moreover, H-7 exhibited a correlation with H-17, supporting that H-17 and the hydroxy group at C-8 were positioned on the β- and α-positions at C-17 and C-8 in the γ-lactone moiety of **2** by modeling analysis. Fortunately, the methylene protons of the *n*-butyrate group at δ~H~ 2.21 exhibited correlation with H-2, indicating that the *n*-butyrate group should be positioned at C-3, and the remaining acetoxy group is positioned at C-14, an oxymethine at δ~C~ 73.5.

![The computer-generated model of **2** using MM2 force field calculations and the calculated distances (Å) between selected protons with key NOESY correlations.](marinedrugs-13-01037-g002){#marinedrugs-13-01037-f002}

In the*in vitro* anti-inflammatory activity test, the upregulation of the pro-inflammatory iNOS (inducible nitric oxide synthase) and COX-2 (cyclooxygenase-2) protein expression of LPS (lipopolysaccharide)-stimulated RAW264.7 macrophage cells was evaluated using immunoblot analysis. At a concentration of 10 μM, Compounds **1** and **2** were found to significantly reduce the levels of iNOS to 23.67% ± 1.86% and 31.71% ± 8.75%, respectively, relative to the control cells stimulated with LPS only ([Figure 3](#marinedrugs-13-01037-f003){ref-type="fig"}). Thus, Compounds**1** and **2**might be promising as anti-inflammatory agents, as they do not exhibit cytotoxicity to RAW264.7 macrophage cells.

![Effects of Compounds **1**and **2**on pro-inflammatory iNOS and COX-2 protein expression in the LPS-stimulated murine macrophage cell line, RAW264.7. (**A**) Relative density of iNOS immunoblot; (**B**) relative density of COX-2 immunoblot. The relative intensity of the LPS-stimulated group was taken to be 100%. Band intensities were quantified by densitometry and are indicated as the percent change relative to that of the LPS-stimulated group. Compounds **1**, **2** and dexamethasone (Dex) significantly inhibited LPS-induced iNOS protein expression in macrophages. The experiment was repeated three times (**\****p* \< 0.05, significantly different from the LPS-stimulated group).](marinedrugs-13-01037-g003){#marinedrugs-13-01037-f003}

3. Experimental Section
=======================

3.1. General Experimental Procedures
------------------------------------

Optical rotation values were measured with a Jasco P-1010 digital polarimeter (Japan Spectroscopic Corporation, Tokyo, Japan). IR spectra were obtained on a Varian Digilab FTS 1000 FT-IR spectrophotometer (Varian Inc., Palo Alto, CA, USA); peaks are reported in cm^−1^. NMR spectra were recorded on a Varian Mercury Plus 400 NMR spectrometer (Varian Inc., Palo Alto, CA, USA) using the residual CHCl~3~ signal (δ~H~ 7.26 ppm) as the internal standard for ^1^H NMR and CDCl~3~ (δ~C~ 77.1 ppm) for ^13^C NMR. Coupling constants (*J*) are given in Hz. ESIMS and HRESIMS were recorded using a Bruker 7 Tesla solariX FTMS system (Bruker, Bremen, Germany). Column chromatography was performed on silica gel (230--400 mesh, Merck, Darmstadt, Germany). TLC was carried out on precoated Kieselgel 60 F~254~ (0.25 mm, Merck, Darmstadt, Germany); spots were visualized by spraying with 10% H~2~SO~4~ solution followed by heating. Normal-phase HPLC (NP-HPLC) was performed using a system comprised of a Hitachi L-7110 pump (Hitachi Ltd., Tokyo, Japan), a Hitachi L-7455 photodiode array detector (Hitachi Ltd., Tokyo, Japan) and a Rheodyne 7725 injection port (Rheodyne LLC, Rohnert Park, CA, USA). A semi-preparative normal-phase column (Hibar 250 × 10 mm, LiChrospher Si 60, 5 μm, Merck, Darmstadt, Germany) was used for HPLC. The reverse phase HPLC (NP-HPLC) was performed using a system comprised of a Hitachi L-7100 pump (Hitachi Ltd., Tokyo, Japan), a Hitachi L-2455 photodiode array detector (Hitachi Ltd., Tokyo, Japan), a Rheodyne 7725 injection port (Rheodyne LLC., Rohnert Park, CA, USA) and a Varian Polaris 5 C-18-A column (25 cm × 10 mm, 5 μm).

3.2. Animal Material
--------------------

Specimens of the octocorals *Briareum* sp. were collected by hand using scuba equipment off the coast of southern Taiwan in July, 2011, and stored in a freezer until extraction. A voucher specimen (NMMBA-TW-SC-2011-77) was deposited in the National Museum of Marine Biology and Aquarium. This organism was identified by comparison with previous descriptions \[[@B45-marinedrugs-13-01037],[@B46-marinedrugs-13-01037],[@B47-marinedrugs-13-01037],[@B48-marinedrugs-13-01037],[@B49-marinedrugs-13-01037]\].

3.3. Extraction and Isolation
-----------------------------

Sliced bodies of *Briareum* sp. (wet weight, 6.32 kg; dry weight, 2.78 kg) were extracted with a mixture of methanol (MeOH) and dichloromethane (DCM) (1:1). The extract was partitioned between ethyl acetate (EtOAc) and H~2~O. The EtOAc layer was separated on silica gel and eluted using *n*-hexane/EtOAc (stepwise, 100:1, pure EtOAc) to yield 18 fractions, A--R. Fractions M, N, O and P were combined and further separated on silica gel and eluted using *n*-hexane/EtOAc (stepwise, 4:1, pure EtOAc) to afford 30 fractions, M1--M30. Fraction M4 was further separated by normal-phase HPLC (NP-HPLC) using a mixture of *n*-hexane and EtOAc as the mobile phase to afford **2** (2:1, 0.7 mg). Fraction Q was chromatographed on silica gel and eluted using *n*-hexane/EtOAc (stepwise, 4:1, pure EtOAc) to afford 20 fractions, Q1--Q20. Fraction Q1 was separated by reverse-phase HPLC (RP-HPLC), using a mixture of acetonitrile and H~2~O as the mobile phase to afford **1** (30:70, 0.7 mg).

Briarenolide K (**1**): white powder; mp 215--216 °C; $\left\lbrack \alpha \right\rbrack_{D}^{27}$ −291 (*c* 0.2, CHCl~3~); IR (neat) ν~max~ 3366, 1781, 1733 cm^−1^; ^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data (see [Table 1](#marinedrugs-13-01037-t001){ref-type="table"}); ESIMS: *m/z* 561 \[M + Na\]^+^; HRESIMS: *m/z* 561.19435 (calcd. for C~26~H~34~O~12~ + Na, 561.19425).

Briarenolide L (**2**): white powder; mp 110--111 °C; $\left\lbrack \alpha \right\rbrack_{D}^{27}$ −177 (*c* 0.2, CHCl~3~); IR (neat) ν~max~ 3461, 1780, 1739 cm^−1^; ^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data (see [Table 2](#marinedrugs-13-01037-t002){ref-type="table"}); ESIMS: *m/z* 601 \[M + Na\]^+^; HRESIMS: *m/z* 601.26221 (calcd. for C~30~H~42~O~11~ + Na, 601.26193).

3.4. In Vitro Anti-Inflammatory Assay
-------------------------------------

The murine macrophage (RAW264.7) cell line was purchased from ATCC. The*in vitro* anti-inflammatory activity of Compounds **1** and **2** was measured by examining the inhibition of lipopolysaccharide (LPS)-induced upregulation of pro-inflammatory iNOS (inducible nitric oxide synthase) and COX-2 (cyclooxygenase-2) protein expression in macrophage cells using Western blotting analysis \[[@B52-marinedrugs-13-01037],[@B53-marinedrugs-13-01037],[@B54-marinedrugs-13-01037]\]. Briefly, inflammation in macrophages was induced by incubating them for 16 h in a medium containing only LPS (10 ng/mL) without compounds. For the anti-inflammatory activity assay, Compounds **1**, **2** and dexamethasone (10 μM) were added to the cells 10 min before the LPS challenge. The cells were then for western blot analysis. The immunoreactivity data were calculated with respect to the average optical density of the corresponding LPS-stimulated group. For statistical analysis, the data were analyzed by a one-way analysis of variance (ANOVA), followed by the Student--Newman--Keuls *post hoc* test for multiple comparisons. A significant difference was defined as a *p*-value of \<0.05.

4. Conclusions
==============

Our continuing investigations demonstrated that the octocoral, *Briareum* sp., is a good source of bioactive substances. Compounds **1** and **2** are potentially anti-inflammatory and may become lead compounds in future marine anti-inflammation drug development \[[@B55-marinedrugs-13-01037],[@B56-marinedrugs-13-01037]\]. These results suggest that continuing investigation of novel secondary metabolites together with the potentially useful bioactivities from this marine organism are worthwhile for future drug development. The octocoral *Briareum* sp. will be transplanted to culturing tanks located in the National Museum of Marine Biology and Aquarium, Taiwan, for extraction of additional natural products to establish a stable supply of bioactive material.
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